跳至主要内容
临床试验/CTRI/2024/12/077910
CTRI/2024/12/077910招募中不适用

Effectiveness of early administration of fludrocortisone in septic shock: A prospective, Double Blind, Randomized control trial.

All India Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
154
试验地点
1
主要终点
To evaluate the effect of early administration of fludrocortisone and vasopressor-free days in early septic shock within the first 14 days of recruitment.

研究概览

简要总结

To evaluate the effect of early administration of fludrocortisone and its effect in septic shock resolution. Recruitment of the cases will be started from 01/01/2025 till sample size is completed.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Adult patients with septic shock within 24 hours of initiation of norepinephrine.

排除标准

  • Age less than 18 years and more than 75 years.
  • Pregnant and lactating patients, Patients with known history of chronic kidney disease, chronic liver disease, congestive heart failure, patients with hypernatremia and hypokalemia, high vasopressor requirement are excluded from the study.

结局指标

主要结局

To evaluate the effect of early administration of fludrocortisone and vasopressor-free days in early septic shock within the first 14 days of recruitment.

时间窗: At baseline and within first 14 days of recruitment

次要结局

  • • Duration of shock (Total days on vasopressor)(• Total daily vasopressors dose from days 1to14.)

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Viswanath S

AIIMS, New Delhi

研究点 (1)

Loading locations...

相似试验

Is the blood pressure corrected by the tablet... | 临床试验